InsiderTrades

Form 4 for GEHC GE HealthCare

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001628280-23-006434 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-03 2023-03-01+ GEHC Makela Jan CEO, Imaging F - Tax $75.22 -5,014 69.5K -7% -$377.2K
D 2023-03-03 2023-03-01 GEHC Makela Jan CEO, Imaging A - Grant $0.00 +9,130 74.5K +14% $0
D 2023-03-03 2023-03-01 GEHC Makela Jan CEO, Imaging A - Grant — +25.5K 25.5K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.01 per share 2023-03-01 F D 3,489 $75.30 71,005 D — — (F3) Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
2 Common Common Stock, par value $0.01 per share 2023-03-01 A A 9,130 $0.00 74,494 D — — (F2) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F1) Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026.
3 Common Common Stock, par value $0.01 per share 2023-03-02 F D 1,525 $75.04 69,480 D — — (F3) Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
4 Derivative Employee Stock Option (right to buy) 2023-03-01 A A 25,472 — 25,472 D $75.30 · — to 2033-03-01 25,472 Common Stock, par value $0.01 per share (F4) Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.